A book authored by Dr. Nicholas A. Peppas from The University of Texas at Austin has been published by Horizon Scientific Press as the first book dedicated to nanotechnology in drug delivery.
Peppas, the Fletcher Stuckey Pratt Chair in Engineering and professor of chemical engineering, biomedical engineering and pharmaceutics, edited the book along with two former doctoral students from his laboratory. The co-editors of "Nanotechnology in Therapeutics: Current Technology and Applications" are Professor J. Zachary Hilt of the University of Kentucky, and Dr J. Brock Thomas of Eastman Chemical Co.
Nanotechnology is a multidisciplinary field covering a large and diverse array of devices and materials in nanometer scale, derived from engineering, physics, chemistry and biology. The field of applied nanotechnology in medicine is growing fast and the application of nanotechnology to therapeutics has led to advances in drug delivery, biomaterials, biomedical devices, intelligent processes and in many other areas of medicine and applied biomedical sciences.
The authors of this volume describe and discuss current technology and the applications of nanoparticles and nanostructures in various aspects of therapeutics and drug delivery. Entire chapters are devoted to specific applications of nanotechnology such as cancer therapy, bone disorders and diabetes.
The up-to-date chapters cover: chronobiology, chronopharmacology and chronotherapeutics, polymeric gene delivery vectors, biohybrid materials, biomimetic systems, hydrogel nanocomposites, star polymers and dendrimers, ionic nanoparticulate systems, nanospheres and nanoparticles.
A table of contents of the new book can be found at: www.horizonpress.com/hsp/books/nanot.html
